U.S. Patent No. 6,622,036: Method for classifying and treating physiologic brain imbalances using quantitative EEG.
- Assignee(s): CNS Response, Inc
- Inventor(s): Stephen Suffin
- Technology Category: EEG
- Issue Date: September 16, 2003
The ‘036 patent discloses the application of quantified EEG to brain imbalances (e.g., physiological imbalances). The value delivered by using an EEG device entirely depends on the ability to understand signals generated by the EEG device. Quantitative analysis of these signals has become a critical aspect in EEG signal processing. The claims of the 036′ patent explicitly exclude coverage of psychiatric diagnoses, potentially presenting either an easy-design around or infringement defense argument. However, the ‘036 patent otherwise appears to have extremely broad claim coverage of quantitative assessments for medication treatments — one of the primary factors making it a key non-invasive neurotechnology patent.
Neurophysiologic information such as quantitative electroencephalography (QEEG) is used in a method for classifying, diagnosing, and treating physiologic brain imbalances. Neurophysiologic information is also used to guide sample selection in clinical tests for psychopharmacologic drug candidates. Finally, neurophysiologic information is used for remotely assessing and treating patients with physiologic brain imbalances.
Illustrative Claim 1. A method for treating physiologic brain imbalances, comprising: obtaining neurophysiologic information from a patient, quantifying the neurophysiologic information, and correlating the quantified neurophysiologic information to medication therapy responsivity profiles, without regard to psychiatric diagnostic category.
To learn more about market data, trends and leading companies in the digital brain health space –digital platforms for brain/ cognitive assessment, monitoring and enhancement– check out this market report. To learn more about our analysis of 10,000+ patent filings, check out this IP & innovation neurotech report.